Citations (68)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Anne M. Delany. (2010) Matricellular proteins osteopontin and osteonectin/SPARC in pancreatic carcinoma. Cancer Biology & Therapy 10:1, pages 65-67.
Read now
Read now
Vitor Faca & Samir Hanash. (2007) In-depth quantitative proteomics for pancreatic cancer biomarker discovery. Expert Opinion on Medical Diagnostics 1:1, pages 81-89.
Read now
Read now
Shalini Jain, Goutam Chakraborty, Anuradha Bulbule, Rajinder Kaur & Gopal C Kundu. (2007) Osteopontin: an emerging therapeutic target for anticancer therapy. Expert Opinion on Therapeutic Targets 11:1, pages 81-90.
Read now
Read now
Articles from other publishers (65)
Yue-Chao Qin, Xin Yan, Xiao-Lin Yuan, Wei-Wei Yu & Fan-Jie Qu. (2023)
Osteopontin promotes gastric cancer progression
via
phosphatidylinositol-3-kinase/protein kinase B/mammalian target of rapamycin signaling pathway
. World Journal of Gastrointestinal Oncology 15:9, pages 1544-1555.
Crossref
Crossref
Tomas Koltai. (2023) Earlier Diagnosis of Pancreatic Cancer: Is It Possible?. Cancers 15:18, pages 4430.
Crossref
Crossref
Shigeki Fukusada, Takaya Shimura, Makoto Natsume, Ruriko Nishigaki, Yusuke Okuda, Hiroyasu Iwasaki, Naomi Sugimura, Mika Kitagawa, Takahito Katano, Mamoru Tanaka, Keiji Ozeki, Eiji Kubota, Kazuki Hayashi & Hiromi Kataoka. (2023) Osteopontin secreted from obese adipocytes enhances angiogenesis and promotes progression of pancreatic ductal adenocarcinoma in obesity. Cellular Oncology.
Crossref
Crossref
Sai V. Chitti, Taeyoung Kang, Pamali Fonseka, Akbar L. Marzan, Sarah Stewart, Sanjay Shahi, Kyle Bramich, Ching‐Seng Ang, Mohashin Pathan, Sriram Gummadi & Suresh Mathivanan. (2023) Proteomic analysis of the small extracellular vesicles and soluble secretory proteins from cachexia inducing and non‐inducing cancer cells. PROTEOMICS 23:15.
Crossref
Crossref
Ashish Manne, Anup Kasi, Ashwini Kumar Esnakula & Ravi Kumar Paluri. (2023) Predictive Value of MUC5AC Signature in Pancreatic Ductal Adenocarcinoma: A Hypothesis Based on Preclinical Evidence. International Journal of Molecular Sciences 24:9, pages 8087.
Crossref
Crossref
Matthew A. Firpo, Kenneth M. Boucher, Josh Bleicher, Gayatri D. Khanderao, Alessandra Rosati, Katherine E. Poruk, Sama Kamal, Liberato Marzullo, Margot De Marco, Antonia Falco, Armando Genovese, Jessica M. Adler, Vincenzo De Laurenzi, Douglas G. Adler, Kajsa E. Affolter, Ignacio Garrido-Laguna, Courtney L. Scaife, M. Caterina Turco & Sean J. Mulvihill. (2023) Multianalyte Serum Biomarker Panel for Early Detection of Pancreatic Adenocarcinoma. JCO Clinical Cancer Informatics:7.
Crossref
Crossref
Zhuce Shao & Shuxiong Bi. (2023) Endocrine regulation and metabolic mechanisms of osteopontin in the development and progression of osteosarcoma, metastasis and prognosis. Frontiers in Endocrinology 13.
Crossref
Crossref
Wen Gao, Dongli Liu, Haiyan Sun, Zhuyan Shao, Peipei Shi, Tingting Li, Sheng Yin & Tao Zhu. (2022) SPP1 is a prognostic related biomarker and correlated with tumor-infiltrating immune cells in ovarian cancer. BMC Cancer 22:1.
Crossref
Crossref
Qi Wang, Huizhi Wang, Yuntao Ding, Mengtian Wan & Min Xu. (2022) The Role of Adipokines in Pancreatic Cancer. Frontiers in Oncology 12.
Crossref
Crossref
Weijiang WuHanqing YangZhutao WangZhijian ZhangXiaodong LuWenjing YangXiayue XuYinuo JiangYan LiXin Fan & Qixiang Shao. (2021) A Noncanonical Hedgehog Signaling Exerts a Tumor-Promoting Effect on Pancreatic Cancer Cells Via Induction of Osteopontin Expression. Cancer Biotherapy and Radiopharmaceuticals.
Crossref
Crossref
Malak Hassn Mesrati, Saiful Effendi Syafruddin, M. Aiman Mohtar & Amir Syahir. (2021) CD44: A Multifunctional Mediator of Cancer Progression. Biomolecules 11:12, pages 1850.
Crossref
Crossref
Yuqing Zhang, Jingxuan Yang, Michael S. Bronze, Courtney W. Houchen & Min Li. (2021) Interplay of Tumor Microenvironment Factors and Cancer Stem Cell Enrichment in Pancreatic Ductal Adenocarcinoma. Gastroenterology 161:6, pages 1800-1802.
Crossref
Crossref
Palanisamy Nallasamy, Rama Krishna Nimmakayala, Saswati Karmakar, Frank Leon, Parthasarathy Seshacharyulu, Imayavaramban Lakshmanan, Satyanarayana Rachagani, Kavita Mallya, Chunmeng Zhang, Quan P. Ly, Molly S. Myers, Lindenberger Josh, Corinn E. Grabow, Shailendra K. Gautam, Sushil Kumar, Subodh M. Lele, Maneesh Jain, Surinder K. Batra & Moorthy P. Ponnusamy. (2021) Pancreatic Tumor Microenvironment Factor Promotes Cancer Stemness via SPP1–CD44 Axis. Gastroenterology 161:6, pages 1998-2013.e7.
Crossref
Crossref
Audrey M Hendley, Arjun A Rao, Laura Leonhardt, Sudipta Ashe, Jennifer A Smith, Simone Giacometti, Xianlu L Peng, Honglin Jiang, David I Berrios, Mathias Pawlak, Lucia Y Li, Jonghyun Lee, Eric A Collisson, Mark S Anderson, Gabriela K Fragiadakis, Jen Jen Yeh, Chun Jimmie Ye, Grace E Kim, Valerie M Weaver & Matthias Hebrok. (2021) Single-cell transcriptome analysis defines heterogeneity of the murine pancreatic ductal tree. eLife 10.
Crossref
Crossref
Hannah R. Moorman, Dakota Poschel, John D. Klement, Chunwan Lu, Priscilla S. Redd & Kebin Liu. (2020) Osteopontin: A Key Regulator of Tumor Progression and Immunomodulation. Cancers 12:11, pages 3379.
Crossref
Crossref
Sonia Zaghdoudi, Emilie Decaup, Ismahane Belhabib, Rémi Samain, Stéphanie Cassant‐Sourdy, Julia Rochotte, Alexia Brunel, David Schlaepfer, Jérome Cros, Cindy Neuzillet, Manon Strehaiano, Amandine Alard, Richard Tomasini, Vinothini Rajeeve, Aurélie Perraud, Muriel Mathonnet, Oliver MT Pearce, Yvan Martineau, Stéphane Pyronnet, Corinne Bousquet & Christine Jean. (2020)
FAK
activity in cancer‐associated fibroblasts is a prognostic marker and a druggable key metastatic player in pancreatic cancer
. EMBO Molecular Medicine 12:11.
Crossref
Crossref
Andrii Khomiak, Marius Brunner, Maximilian Kordes, Stina Lindblad, Rainer Christoph Miksch, Daniel Öhlund & Ivonne Regel. (2020) Recent Discoveries of Diagnostic, Prognostic and Predictive Biomarkers for Pancreatic Cancer. Cancers 12:11, pages 3234.
Crossref
Crossref
Christina R Adams, Htet Htwe Htwe, Timothy Marsh, Aprilgate L Wang, Megan L Montoya, Lakshmipriya Subbaraj, Aaron D Tward, Nabeel Bardeesy & Rushika M Perera. (2019) Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer. eLife 8.
Crossref
Crossref
Oskar Franklin, Ola Billing, Daniel Öhlund, Anette Berglund, Carl Herdenberg, Wanzhong Wang, Urban Hellman & Malin Sund. (2018) Novel prognostic markers within the CD44‐stromal ligand network in pancreatic cancer. The Journal of Pathology: Clinical Research 5:2, pages 130-141.
Crossref
Crossref
Junyu Cao, Jie Li, Liankang Sun, Tao Qin, Ying Xiao, Ke Chen, Weikun Qian, Wanxing Duan, Jianjun Lei, Jiguang Ma, Qingyong Ma & Liang Han. (2018) Hypoxia‐driven paracrine osteopontin/integrin αvβ3 signaling promotes pancreatic cancer cell epithelial–mesenchymal transition and cancer stem cell‐like properties by modulating forkhead box protein M1. Molecular Oncology 13:2, pages 228-245.
Crossref
Crossref
Xingwen Han, Wenji Wang, Jingjing He, Lei Jiang & Xun Li. (2019) Osteopontin as a biomarker for osteosarcoma therapy and prognosis (Review). Oncology Letters.
Crossref
Crossref
Artur Anisiewicz, Beata Filip-Psurska, Agata Pawlik, Anna Nasulewicz-Goldeman, Tomasz Piasecki, Konrad Kowalski, Magdalena Maciejewska, Joanna Jarosz, Joanna Banach, Diana Papiernik, Andrzej Mazur, Andrzej Kutner, Jeanette A Maier & Joanna Wietrzyk. (2019) Calcitriol Analogues Decrease Lung Metastasis but Impair Bone Metabolism in Aged Ovariectomized Mice Bearing 4T1 Mammary Gland Tumours. Aging and disease 10:5, pages 977.
Crossref
Crossref
R. Gehlig. (2019) Ossifikationsprozesse als treibende Kräfte für die Krebserkrankung. Der Merkurstab 72:5, pages 364-370.
Crossref
Crossref
Agata Pawlik, Artur Anisiewicz, Beata Filip-Psurska, Marcin Nowak, Eliza Turlej, Justyna Trynda, Joanna Banach, Paweł Gretkierewicz & Joanna Wietrzyk. (2018) Calcitriol and Its Analogs Establish the Immunosuppressive Microenvironment That Drives Metastasis in 4T1 Mouse Mammary Gland Cancer. International Journal of Molecular Sciences 19:7, pages 2116.
Crossref
Crossref
Hailin Zhao, Qian Chen, Azeem Alam, Jiang Cui, Ka Chun Suen, Aurelie Pac Soo, Shiori Eguchi, Jianteng Gu & Daqing Ma. (2018) The role of osteopontin in the progression of solid organ tumour. Cell Death & Disease 9:3.
Crossref
Crossref
Tomoya Iida, Kohei Wagatsuma, Daisuke Hirayama & Hiroshi Nakase. (2017) Is Osteopontin a Friend or Foe of Cell Apoptosis in Inflammatory Gastrointestinal and Liver Diseases?. International Journal of Molecular Sciences 19:1, pages 7.
Crossref
Crossref
Emma Eriksson, Ioanna Milenova, Jessica Wenthe, Magnus Ståhle, Justyna Leja-Jarblad, Gustav Ullenhag, Anna Dimberg, Raphael Moreno, Ramon Alemany & Angelica Loskog. (2017) Shaping the Tumor Stroma and Sparking Immune Activation by CD40 and 4-1BB Signaling Induced by an Armed Oncolytic Virus. Clinical Cancer Research 23:19, pages 5846-5857.
Crossref
Crossref
Hannah M. Komar, Phil A. Hart, Zobeida Cruz-Monserrate, Darwin L. Conwell & Gregory B. Lesinski. (2017) Local and Systemic Expression of Immunomodulatory Factors in Chronic Pancreatitis. Pancreas 46:8, pages 986-993.
Crossref
Crossref
Valerya Feygenzon, Shelly Loewenstein, Nir Lubezky, Metsada Pasmanic-Chor, Osnat Sher, Joseph M. Klausner & Guy Lahat. (2017) Unique cellular interactions between pancreatic cancer cells and the omentum. PLOS ONE 12:6, pages e0179862.
Crossref
Crossref
Sven H Loosen, Ulf P Neumann, Christian Trautwein, Christoph Roderburg & Tom Luedde. (2017) Current and future biomarkers for pancreatic adenocarcinoma. Tumor Biology 39:6, pages 101042831769223.
Crossref
Crossref
Samantha Lynn HamiltonBlake FerandoAsha Sarah EapenJennifer Chian YuAnita Rose Joy. (2016) Cancer Secretome May Influence BSP and DSP Expression in Human Salivary Gland Cells. Journal of Histochemistry & Cytochemistry 65:3, pages 139-151.
Crossref
Crossref
Martin C. Whittle & Sunil R. Hingorani. 2017. RUNX Proteins in Development and Cancer. RUNX Proteins in Development and Cancer
333
352
.
Sebastian Rasch, Irena Valantiene, Artautas Mickevicius, Sebastian Beer, Jonas Rosendahl, Richard M. Charnley & Stuart M. Robinson. (2016) Chronic pancreatitis: Do serum biomarkers provide an association with an inflammageing phenotype?. Pancreatology 16:5, pages 708-714.
Crossref
Crossref
B. Čunderlíková. (2016) Clinical significance of immunohistochemically detected extracellular matrix proteins and their spatial distribution in primary cancer. Critical Reviews in Oncology/Hematology 105, pages 127-144.
Crossref
Crossref
Jana Rychlíková, Marek Vecka, Marie Jáchymová, Jaroslav Macášek, Petr Hrabák, Miroslav Zeman, Lucie Vávrová, Jan Řoupal, Tomáš Krechler & Aleš ák. (2016) Osteopontin as a discriminating marker for pancreatic cancer and chronic pancreatitis. Cancer Biomarkers 17:1, pages 55-65.
Crossref
Crossref
Jian-Jun LiHong-Yu LiFei Gu. (2014) Diagnostic Significance of Serum Osteopontin Level for Pancreatic Cancer: A Meta-Analysis. Genetic Testing and Molecular Biomarkers 18:8, pages 580-586.
Crossref
Crossref
Zhe Huang & Fang Liu. (2014) Diagnostic value of serum carbohydrate antigen 19-9 in pancreatic cancer: a meta-analysis. Tumor Biology 35:8, pages 7459-7465.
Crossref
Crossref
Thomas E. Kruger, Andrew H. Miller, Andrew K. Godwin & Jinxi Wang. (2014) Bone sialoprotein and osteopontin in bone metastasis of osteotropic cancers. Critical Reviews in Oncology/Hematology 89:2, pages 330-341.
Crossref
Crossref
Ferda Kaleağasıoğlu. (2014) SIBLINGs and SPARC families: Their emerging roles in pancreatic cancer. World Journal of Gastroenterology 20:40, pages 14747.
Crossref
Crossref
Ozgur Mete, Caroline Hayhurst, Hussein Alahmadi, Eric Monsalves, Hasan Gucer, Fred Gentili, Shereen Ezzat, Sylvia L. Asa & Gelareh Zadeh. (2013) The Role of Mediators of Cell Invasiveness, Motility, and Migration in the Pathogenesis of Silent Corticotroph Adenomas. Endocrine Pathology 24:4, pages 191-198.
Crossref
Crossref
Katherine E. Poruk, Matthew A. Firpo, Courtney L. Scaife, Douglas G. Adler, Lyska L. Emerson, Kenneth M. Boucher & Sean J. Mulvihill. (2013) Serum Osteopontin and Tissue Inhibitor of Metalloproteinase 1 as Diagnostic and Prognostic Biomarkers for Pancreatic Adenocarcinoma. Pancreas 42:2, pages 193-197.
Crossref
Crossref
Chang-Han Chen, Li-Yen Shiu, Li-Jen Su, Chi-Ying F Huang, Shun-Chen Huang, Chao-Cheng Huang, Yu-Fang Yin, Wei-Sheng Wang, Hsin-Ting Tsai, Fu-Min Fang, Wan-Chu Chuang, Hong-Chang Kang & Chung-Feng Hwang. (2012) FLJ10540 is associated with tumor progression in nasopharyngeal carcinomas and contributes to nasopharyngeal cell proliferation, and metastasis via osteopontin/CD44 pathway. Journal of Translational Medicine 10:1.
Crossref
Crossref
Li Zhao, Yalin Wang, Nan Qu, Chen Huang & Lijun Chen. (2012) Significance of Plasma Osteopontin Levels in Patients with Bladder Urothelial Carcinomas. Molecular Diagnosis & Therapy 16:5, pages 311-316.
Crossref
Crossref
Hassan Adwan. (2012) Few genes are associated with the capability of pancreatic ductal adenocarcinoma cells to grow in the liver of nude rats. Oncology Reports.
Crossref
Crossref
Amy L. Collins, Jonathan Rock, Lavina Malhotra, Wendy L. Frankel & Mark Bloomston. (2012) Osteopontin Expression is Associated with Improved Survival in Patients with Pancreatic Adenocarcinoma. Annals of Surgical Oncology 19:8, pages 2673-2678.
Crossref
Crossref
H Adwan, M Zhivkova-Galunska, R Georges, E Eyol, J Kleeff, N A Giese, H Friess, F Bergmann & M R Berger. (2011) Expression of HOXC8 is inversely related to the progression and metastasis of pancreatic ductal adenocarcinoma. British Journal of Cancer 105:2, pages 288-295.
Crossref
Crossref
Margherita Gaviraghi, Patrizia Tunici, Silvia Valensin, Marco Rossi, Cinzia Giordano, Letizia Magnoni, Mario Dandrea, Licia Montagna, Rossana Ritelli, Aldo Scarpa & Annette Bakker. (2011) Pancreatic cancer spheres are more than just aggregates of stem marker-positive cells. Bioscience Reports 31:1, pages 45-55.
Crossref
Crossref
Matthias Bache, Matthias Kappler, Henri Wichmann, Swetlana Rot, Antje Hahnel, Thomas Greither, Harun M Said, Matthias Kotzsch, Peter W?rl, Helge Taubert & Dirk Vordermark. (2010) Elevated tumor and serum levels of the hypoxia-associated protein osteopontin are associated with prognosis for soft tissue sarcoma patients. BMC Cancer 10:1.
Crossref
Crossref
Ru Chen, David A. Crispin, Sheng Pan, Sarah Hawley, Martin W. McIntosh, Damon May, Hoda Anton-Culver, Argyrios Ziogas, Mary P. Bronner & Teresa A. Brentnall. (2010) Pilot Study of Blood Biomarker Candidates for Detection of Pancreatic Cancer. Pancreas 39:7, pages 981-988.
Crossref
Crossref
Keisuke Ohno, Hidefumi Nishimori, Takahiro Yasoshima, Kenjiro Kamiguchi, Fumitake Hata, Rika Fukui, Koichi Okuya, Yasutoshi Kimura, Ryuichi Denno, Shigeyuki Kon, Toshimitsu Uede, Noriyuki Sato & Koichi Hirata. (2010) Inhibition of osteopontin reduces liver metastasis of human pancreatic cancer xenografts injected into the spleen in a mouse model. Surgery Today 40:4, pages 347-356.
Crossref
Crossref
S.G. Gao, K.H. Li, K.B. Zeng, M. Tu, M. Xu & G.H. Lei. (2010) Elevated osteopontin level of synovial fluid and articular cartilage is associated with disease severity in knee osteoarthritis patients. Osteoarthritis and Cartilage 18:1, pages 82-87.
Crossref
Crossref
Siina Junnila, Arto Kokkola, Toru Mizuguchi, Koichi Hirata, Marja-Liisa Karjalainen-Lindsberg, Pauli Puolakkainen & Outi Monni. (2010)
Gene expression analysis identifies over-expression of
CXCL1
,
SPARC
,
SPP1
, and
SULF1
in gastric cancer
. Genes, Chromosomes and Cancer 49:1, pages 28-39.
Crossref
Crossref
Chih-Yen Chien, Chih-Ying Su, Hui-Ching Chuang, Fu-Min Fang, Hsuan-Ying Huang, Chang-Han Chen, Ching-Mei Chen & Chao-Cheng Huang. (2009) Comprehensive study on the prognostic role of osteopontin expression in oral squamous cell carcinoma. Oral Oncology 45:9, pages 798-802.
Crossref
Crossref
Jennifer Sullivan, Laurel Blair, Amer Alnajar, Tamer Aziz, Chee Yuan Ng, Galina Chipitsyna, Qiaoke Gong, Agnes Witkiewicz, Georg F. Weber, David T. Denhardt, Charles J. Yeo & Hwyda A. Arafat. (2009) Expression of a prometastatic splice variant of osteopontin, OPNC, in human pancreatic ductal adenocarcinoma. Surgery 146:2, pages 232-240.
Crossref
Crossref
Lara H. El Touny & Partha P. Banerjee. (2009) Identification of a Biphasic Role for Genistein in the Regulation of Prostate Cancer Growth and Metastasis. Cancer Research 69:8, pages 3695-3703.
Crossref
Crossref
Annarita Farina, Jean-Marc Dumonceau, Jean-Louis Frossard, Antoine Hadengue, Denis F. Hochstrasser & Pierre Lescuyer. (2008) Proteomic Analysis of Human Bile from Malignant Biliary Stenosis Induced by Pancreatic Cancer. Journal of Proteome Research 8:1, pages 159-169.
Crossref
Crossref
Akeila Bellahcène, Vincent Castronovo, Kalu U. E. Ogbureke, Larry W. Fisher & Neal S. Fedarko. (2008) Small integrin-binding ligand N-linked glycoproteins (SIBLINGs): multifunctional proteins in cancer. Nature Reviews Cancer 8:3, pages 212-226.
Crossref
Crossref
Hany Kayed, Sandor Bekasi, Shereen Keleg, Christoph W Michalski, Thomas Giese, Helmut Friess & Jörg Kleeff. (2007) BGLAP is expressed in pancreatic cancer cells and increases their growth and invasion. Molecular Cancer 6:1.
Crossref
Crossref
Daniel Hartmann, Klaus Felix, Michael Ehmann, Martina Schnölzer, Sabine Fiedler, Ralf Bogumil, Markus Büchler & Helmut Friess. (2007) Protein Expression Profiling Reveals Distinctive Changes in Serum Proteins Associated With Chronic Pancreatitis. Pancreas 35:4, pages 334-342.
Crossref
Crossref
H Kayed, X Jiang, S Keleg, R Jesnowski, T Giese, M R Berger, I Esposito, M Löhr, H Friess & J Kleeff. (2007) Regulation and functional role of the Runt-related transcription factor-2 in pancreatic cancer. British Journal of Cancer 97:8, pages 1106-1115.
Crossref
Crossref
Bogdan-Dragos Grigoriu, Arnaud Scherpereel, Patrick Devos, Bachar Chahine, Marc Letourneux, Pierre Lebailly, Marc Grégoire, Henri Porte, Marie-Christine Copin & Philippe Lassalle. (2007) Utility of Osteopontin and Serum Mesothelin in Malignant Pleural Mesothelioma Diagnosis and Prognosis Assessment. Clinical Cancer Research 13:10, pages 2928-2935.
Crossref
Crossref
Hany Kayed, Jörg Kleeff, Shereen Keleg, Klaus Felix, Thomas Giese, Martin R. Berger, Markus W. Büchler & Helmut Friess. (2007) Effects of bone sialoprotein on pancreatic cancer cell growth, invasion and metastasis. Cancer Letters 245:1-2, pages 171-183.
Crossref
Crossref
Mark Bloomston, E. Christopher Ellison, Peter Muscarella, Osama Al-Saif, Edward W. Martin, W. Scott Melvin & Wendy L. Frankel. (2006) Stromal Osteonectin Overexpression Is Associated with Poor Outcome in Patients with Ampullary Cancer. Annals of Surgical Oncology 14:1, pages 211-217.
Crossref
Crossref
F. J White, R. C Burghardt, J. Hu, M. M Joyce, T. E Spencer & G. A Johnson. (2006) Secreted phosphoprotein 1 (osteopontin) is expressed by stromal macrophages in cyclic and pregnant endometrium of mice, but is induced by estrogen in luminal epithelium during conceptus attachment for implantation. Reproduction 132:6, pages 919-929.
Crossref
Crossref
Gamze Kilic, Junfeng Wang & Beatriz Sosa-Pineda. (2006) Osteopontin is a novel marker of pancreatic ductal tissues and of undifferentiated pancreatic precursors in mice. Developmental Dynamics 235:6, pages 1659-1667.
Crossref
Crossref